Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Hawkins

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Pharmacogenetics of asthmaGregory A Hawkins, Stephen P Peters
American Journal of Respiratory Cell and Molecular Biology|June 2, 2017
FAM13A, A Fatty Acid Oxidation Switch in Mitochondria. Friend or Foe in Chronic Obstructive Pulmonary Disease Pathogenesis?Gregory A Hawkins, Ana L Mora
Immunology and Allergy Clinics of North America|November 1, 2005
Asthma pharmacogenomicsGregory A Hawkins, Scott T Weiss, Eugene R Bleecker
Pharmacogenomics|February 29, 2008
Clinical consequences of ADRbeta2 polymorphismsGregory A Hawkins, Scott T Weiss, Eugene R Bleecker
DNA Sequence : the Journal of DNA Sequencing and Mapping|September 14, 2007
Identification of coding polymorphisms in human circadian rhythm genes PER1, PER2, PER3, CLOCK, ARNTL, CRY1, CRY2 and TIMELESS in a multi-ethnic screening panelGregory A Hawkins, Deborah A Meyers, Eugene R Bleecker, et al.
Immunology and Allergy Clinics of North America|November 13, 2007
Pharmacogenetics of the beta 2-adrenergic receptor geneVictor E Ortega, Gregory A Hawkins, Stephen P Peters, et al.
International Journal of Molecular Sciences|September 29, 2019
The Need for Multi-Omics Biomarker Signatures in Precision MedicineMichael Olivier, Reto Asmis, Gregory A Hawkins, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 14, 2020
Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R<sup>358</sup>Ala variant groups in amyotrophic lateral sclerosis patientsMarlena Wosiski-Kuhn, James B Caress, Michael S Cartwright, et al.
Infection Control and Hospital Epidemiology|February 22, 2022
A case of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reinfection within ninety days of primary infection in a healthcare workerMindy M Sampson, Kimberly D Reeves, Christopher M Polk, et al.
Immunology|May 9, 2008
Altered editing in cyclic nucleotide phosphodiesterase 8A1 gene transcripts of systemic lupus erythematosus T lymphocytesRobert J Orlowski, Kenneth S O'Rourke, Irene Olorenshaw, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Pharmacogenetics of asthmaGregory A Hawkins, Stephen P Peters
American Journal of Respiratory Cell and Molecular Biology|June 2, 2017
FAM13A, A Fatty Acid Oxidation Switch in Mitochondria. Friend or Foe in Chronic Obstructive Pulmonary Disease Pathogenesis?Gregory A Hawkins, Ana L Mora
Immunology and Allergy Clinics of North America|November 1, 2005
Asthma pharmacogenomicsGregory A Hawkins, Scott T Weiss, Eugene R Bleecker
Pharmacogenomics|February 29, 2008
Clinical consequences of ADRbeta2 polymorphismsGregory A Hawkins, Scott T Weiss, Eugene R Bleecker
DNA Sequence : the Journal of DNA Sequencing and Mapping|September 14, 2007
Identification of coding polymorphisms in human circadian rhythm genes PER1, PER2, PER3, CLOCK, ARNTL, CRY1, CRY2 and TIMELESS in a multi-ethnic screening panelGregory A Hawkins, Deborah A Meyers, Eugene R Bleecker, et al.
Immunology and Allergy Clinics of North America|November 13, 2007
Pharmacogenetics of the beta 2-adrenergic receptor geneVictor E Ortega, Gregory A Hawkins, Stephen P Peters, et al.
International Journal of Molecular Sciences|September 29, 2019
The Need for Multi-Omics Biomarker Signatures in Precision MedicineMichael Olivier, Reto Asmis, Gregory A Hawkins, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 14, 2020
Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R<sup>358</sup>Ala variant groups in amyotrophic lateral sclerosis patientsMarlena Wosiski-Kuhn, James B Caress, Michael S Cartwright, et al.
Infection Control and Hospital Epidemiology|February 22, 2022
A case of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reinfection within ninety days of primary infection in a healthcare workerMindy M Sampson, Kimberly D Reeves, Christopher M Polk, et al.
Immunology|May 9, 2008
Altered editing in cyclic nucleotide phosphodiesterase 8A1 gene transcripts of systemic lupus erythematosus T lymphocytesRobert J Orlowski, Kenneth S O'Rourke, Irene Olorenshaw, et al.
Pageof 12